Blackrock Health Sciences Trust
 
 
 
 
基本資料
種類: ETF
費用比率%: 1.13
資產淨值: 44.68
成立日期: 28/03/2005
 
分析
市值分佈:
42.52%
大市值
1.03%
中市值
0.53%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:22) 總持有投資項目: 55  
0%
 
100%
     10大 (30.56%)
代號 名稱 佔比% 持有日期
LLYEli Lilly & Co11.1231/12/2025
GILDGilead Sciences3.9431/03/2026
UNHUnitedhealth Group3.0431/03/2026
VRTXVertex Pharmaceuticals2.6831/03/2026
DHRDanaher Corp1.9431/03/2026
TEVATeva Pharmaceutical Industries Limited1.7231/03/2026
BSXBoston Scientific Corp1.5531/03/2026
ARGXargenx SE1.4631/03/2026
AZNAstraZeneca PLC1.2931/12/2025
CORCencora1.2331/12/2025
REGNRegeneron Pharmaceuticals1.1231/03/2026
BMYBristol-Myers Squibb Co1.1031/03/2026
COGTCogent Biosciences0.9031/03/2026
SGEN--0.8830/09/2023
RYTMRhythm Pharmaceuticals0.7631/03/2026
NVSNovartis AG0.6331/03/2026
GDERFGALDERMA GROUP AG0.6031/03/2026
ALNYAlnylam Pharmaceuticals0.5231/03/2026
MCKMcKesson Corp0.4931/03/2026
MRNAModerna0.4731/03/2026
 1    2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.